ARTICLE | Company News
Medicis, Ansata peptide technology deal
December 14, 2004 8:00 AM UTC
Ansata (La Jolla, Calif.) granted MRX exclusive worldwide rights to develop Ansata's antimicrobial peptide technology, including preclinical compounds discovered using this technology. Ansata will rec...